Edition:
United States

People: CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

79.63USD
22 Sep 2017
Change (% chg)

$0.07 (+0.09%)
Prev Close
$79.56
Open
$79.20
Day's High
$79.90
Day's Low
$78.64
Volume
1,661,236
Avg. Vol
1,432,911
52-wk High
$90.85
52-wk Low
$69.30

Moriarty, Thomas 

Mr. Thomas M. Moriarty is Executive Vice President, General Counsel, Chief Health Strategy Officer of the Company. He was General Counsel of Celgene Corporation, a global biopharmaceutical company, from May 2012 through September 2012; General Counsel and Corporate Secretary of Medco Health Solutions, Inc. (“Medco”), a pharmacy benefit management company, from March 2008 through April 2012; also President of Global Pharmaceutical Strategies of Medco from March 2011 through April 2012; Senior Vice President, Pharmaceutical Strategies and Solutions of Medco from September 2007 through March 2011.

Basic Compensation

Total Annual Compensation, USD 2,776,000
Restricted Stock Awards, USD 999,983
Long-Term Incentive Plans, USD --
All Other, USD 1,174,760
Fiscal Year Total, USD 4,950,740

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 162,192 6,514,140.00
Name Fiscal Year Total

David Dorman

570,200

Larry Merlo

18,359,400

David Denton

5,549,000

Jonathan Roberts

8,631,110

Lisa Bisaccia

--

Stephen Gold

--
As Of  30 Dec 2016